BioWorld

Sep. 14, 1999

View Archived Issues

Berlex Stops MS Betaseron Trial On Advice Of Monitoring Board

Read More

Merck Stops Development Of Synaptic's Lead Compound

Read More

Synsorb Plans Phase III Trial Following Look At CDAD Data

Read More

Other News To Note

Read More

New French Proprietary Drug Packs Double Molecular Punch As Cerebral Ischemia Therapy

Read More

Guilford Raises $45M Privately Through Common Stock Sale

Read More

Affymetrix Soars, Incyte Falls After GeneChip Patent Ruling

Read More